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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A4044 courses, and 760 (1.5%) received 5 courses or more. The time from
diagnosis to when 50% of the subset received TKR was signiﬁcantly
longer (p1 year, an average of 9 months longer than those with no IA
HA. Patients who received 5 courses had a delay in TKR by 3.6 years.
Conclusions: Among 182,022 patients with knee OA, those who
received IA HA had a signiﬁcantly longer time before TKR. More courses
of IA HA injections were associatedwith a longer time toTKR. This study
suggests a signiﬁcant clinical beneﬁt from use of IA HA for OA as delay in
time to TKR can have important clinical and economic implications.Median Time from knee OA diagnosis to TKR by number of courses of IA HA
No IA HA 1 2 3 4 5þ
Days to TKR 114 386 648 875 1054 1312
Years to TKR 0.3 1.1 1.8 2.4 2.9 3.6675
EVALUATION OF THE CLINICAL EFFICACY OF AUTOLOGOUS
CONDITIONED SERUM IN PATIENTS WITH COXARTHROSIS
K. Shirokova, S. Noskov, L. Shirokova. Yaroslavl State Med. Univ.,
Yaroslavl, Russian Federation
Purpose: The aim of this open study was a comparative assessment of
the effectiveness of local therapy with autologous conditioned serum
(ACS) and low molecular weight hyaluronic acid (LHA) in patients with
coxarthrosis.
Methods: The study included 60 patients with ﬁrm coxarthrosis in
accordance with ACR criteria at the age of 55,5 ± 8,7. The main group
(ACS treatment) consisted of 33 (55%) persons. Experimental group
(LHA treatment) consisted of 27 patients who are comparable with the
main group patients in terms of age, BMI, radiographic stage, disease
duration and severity of clinical indicators. ACS was prepared in
accordance with established method and injected intraarticularly (2.5
ml twice a week for three weeks). LHA treatment consisted of 3 weekly
intraarticular injections of 40 mg sodium hyaluronate each. All intra-
articular actions were performed with ultrasound control. Treatment
efﬁciency was evaluated after 1,3 and 6 months after treatment, the
following criteria were used: bodily pain dynamics in accordance with
VAS, morning stiffness module and Womac index functional scale, and
Lequesne index. “Area under the curve” (AUC) approach with estima-
tion of treatment efﬁciency prolongation for 6 months (AUC6) was used
for evaluation of clinical effect retention.
Results: A decrease in pain syndrome intensity according to VAS in hip
joints at 1, 3 and 6 months of treatment in both compared groups was
recorded.However, a signiﬁcant regression was observed in the treat-
ment of pain with ACS in comparison with LHA.After 1 month the
decrease of pain severity in accordancewithVASwas comparable (9.1%, p
¼ 0.40), after 3 and 6 months, pain severity was higher in the LHA group
compared with ACS group (þ 52.5%, p ¼ 0.009 and þ 33.1%, p ¼ 0.047
respectively). AUC6 in case of ACS treatmentwas 35,6% (p¼ 0,011) higher
compared with LHA treatment. Extension of the clinical effectiveness
expressed via "morning stiffness" module of the Womac index AUC6
indicatorwas 55.9% (p¼0.003) higher in case of ACS treatment compared
with LHA treatment. Womac functional scale in case of ACS improved
through all three control timepoints (-23.1% -28.5% -39.1%; p ¼ 0.001).
Same dynamics was observed in LHA group as well (-35.6%, -26.4%; p ¼
0.001 and -20.4%; p ¼ 0.005), however after 6 months of monitoring
more signiﬁcant improvement of articular functionwas recorded within
ACS group compared with LHA (18.3%, p ¼ 0.044). The overall clinical
efﬁcacy in accordancewith Lequesne indexwith a six-monthmonitoring
was comparable in both groups, thedifference cameup to8,8% (p¼ 0,65).
Conclusions: Intensity of pain, stiffness, functional status and overall
clinical severity of coxarthrosis signiﬁcantly and consistently decreased
during therapy with ACS and LHA.However, favorable changes of local
therapy with LHAwere inferior in duration of conservation of treatment
effect of ACS.676
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RABBIT MODEL OF EARLY OSTEOARTHRITIS
S. Kaderli y, E. Chereul z, E. Viguier x, T. Roger x, M. M€oller k,
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Purpose: One of the major challenges of the viscosupplementation (VS)
therapy is the development of more efﬁcient formulations and, to this
end, the use of animal models of osteoarthritis (OA) is still mandatory.
The assessment of VS efﬁcacy is challenging mainly since its structural
effects are subtle. In order to reﬁne preclinical VS efﬁcacy studies and
reduce the number of animals used, there is a crucial need for more
sensitive and discriminant evaluation tools. In this study, we especially
focused on complementary techniques to evaluate OA cartilage in a
rabbit model of early OA.
Methods: Cranial cruciate ligament transection (ACLT) was performed
in the left knee of white New-Zealand rabbits (n¼12) to induce trau-
matic OA. One week post-ACLT and then weekly for 5 weeks, the
operated knees of 6 rabbits were injected with a hyaluronic acid (HA)
containing commercial formulation (Ostenil®, HA group). One group
was injected with saline (operated-control group, n¼6). The con-
tralateral right knees (n¼8) were used as unoperated-controls. End-
point evaluation was done at the 6th week post-ACLT and included:
gross and histological scoring of cartilage lesions, measurement of
cartilage thickness by Equilibrium Partitioning Iodine Contrast micro-
Computed Tomography (EPIC m-CT) as well as the evaluation of the
surface by Scanning Electron Microscopy (SEM).
Results: Gross and histological scorings showed statistical differences
between operated and unoperated knees; however, no difference
between the HA and operated-control groups was evidenced. SEM
revealed that unoperated-control samples had normal smooth to rough
surfaces with discreet cable-like structures. Cartilage from the operated
knees presented rough surfaces and clearly visible cable-like structures,
which might be the sign of cartilage matrix erosion. Finally, mean car-
tilage thickness and volume measured by EPIC m-CT were comparable
for the 3 groups. Interestingly, the use of the thickness distribution
representation showed clear differences in the intact cartilage occur-
rences (i.e. thickness higher or equal to 0.9 mm). Indeed, intact cartilage
proportion decreased statistically from 20% in the unoperated-control
group to 10% in the operated-control group. In addition, intact cartilage
proportion in the HA treated knees was equivalent to unoperated-
control group, highlighting a moderate efﬁcacy of HA which was
detected neither by histology nor by SEM.
Conclusions:Complementary techniqueswere implemented toevaluate
cartilage lesions in a rabbitmodel of earlyOA in order to reﬁne preclinical
VS efﬁcacy studies. This study points out that classical evaluation tools
(macroscopy and histology) are sensitive enough to discriminate
between cartilage from unoperated and operated groups in early OA but
that EPIC-mCTalsopermits the detection of the subtle structural effects of
HA, validating this technique as a powerful evaluation tool.
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EVIDENCE OF IN VIVO DRUG DELIVERY VIA THE TAT PROTEIN
TRANSDUCTION DOMAIN
A. Hamil y, D. Haudenschild z, S. Dowdy y, R. June x. yUniv. of California,
San Diego, La Jolla, CA, USA; zUniv. of California, Davis, Sacramento, CA,
USA; xMontana State Univ., Bozeman, MT, USA
Purpose: Drug delivery to synovial joints is a major limitation for
developing effective treatments for osteoarthritis (OA). Synovial joint
anatomy includes large pores that allow direct transport between
synovial ﬂuid and fenestrated capillaries. This transport preferentially
selects larger molecules to remain within the joint and exports smaller
